Sarah E Dorff
6PUBLICATIONS
83CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 24, 2025
US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia.Nina Kim, E Dianne Pulte, Lori A Ehrlich
|Sep 05, 2025
FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery.Michael I Barbato, Amy K Barone, Stephanie L Aungst
|Aug 27, 2025
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer.Melanie Royce, Mirat Shah, Lijun Zhang
|Jul 01, 2025
FDA Approval Summary: Ivosidenib for Treatment of Adult Patients with Relapsed/Refractory Myelodysplastic Syndrome with an IDH1 Mutation.Ashley C Woods, E Dianne Pulte, Xin Wang
|Jun 14, 2024
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer.Michael I Barbato, Diana Bradford, Yi Ren
|Jun 02, 2023
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors.Elizabeth S Duke, Diana Bradford, Michelle Marcovitz
Pageof 1
Frequent Collaborators
6 joint publications
Richard Pazdur
3 joint publications
Paul G Kluetz
3 joint publications
Vishal Bhatnagar
3 joint publications
Claudia P Miller
3 joint publications
Youwei Bi
3 joint publications
Barbara Scepura
2 joint publications
Idara Ojofeitimi
2 joint publications
Anup K Amatya
2 joint publications
Maritsa Stephenson
2 joint publications
Lauren S L Price
